During the past decade, CarolinaEast Oncology and Hematology Associates conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "CarolinaEast Oncology and Hematology Associates" #1 collaborator was "National Cancer Institute (NCI)" with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "CarolinaEast Oncology and Hematology Associates" are "Estrogen Receptor-positive Breast Cancer" (1 trials), "HER2/Neu Negative" (1 trials), "Malignant Neoplasm" (1 trials), "Stage I Colon Cancer AJCC v8" (1 trials) and "Stage I Rectal Cancer AJCC v8" (1 trials). Many other conditions were trialed in "CarolinaEast Oncology and Hematology Associates" in a lesser frequency.

Most popular intervention types in "CarolinaEast Oncology and Hematology Associates" are "Other" (3 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (2 trials), "Questionnaire Administration" (2 trials), "Dexamethasone" (1 trials), "Fosaprepitant Dimeglumine" (1 trials) and "Fulvestrant" (1 trials). Other intervention names were less common.

The vast majority of trials in "CarolinaEast Oncology and Hematology Associates" are 3 trials for "All" genders.

Currently, there are NaN active trials in "CarolinaEast Oncology and Hematology Associates". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in CarolinaEast Oncology and Hematology Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CarolinaEast Oncology and Hematology Associates, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".